UA103664C2 - 5-β-ПРОИЗВОДНЫЕ 14-β-АНДРОСТАНА ДЛЯ ЛЕЧЕНИЯ ПРОТЕИНУРИИ, ГЛОМЕРУЛОСКЛЕРОЗА И ПОЧЕЧНОЙ НЕДОСТАТОЧНОСТИ - Google Patents

5-β-ПРОИЗВОДНЫЕ 14-β-АНДРОСТАНА ДЛЯ ЛЕЧЕНИЯ ПРОТЕИНУРИИ, ГЛОМЕРУЛОСКЛЕРОЗА И ПОЧЕЧНОЙ НЕДОСТАТОЧНОСТИ

Info

Publication number
UA103664C2
UA103664C2 UAA201112311A UAA201112311A UA103664C2 UA 103664 C2 UA103664 C2 UA 103664C2 UA A201112311 A UAA201112311 A UA A201112311A UA A201112311 A UAA201112311 A UA A201112311A UA 103664 C2 UA103664 C2 UA 103664C2
Authority
UA
Ukraine
Prior art keywords
glomerulosclerosis
proteinuria
treatment
renal failure
derivatives useful
Prior art date
Application number
UAA201112311A
Other languages
English (en)
Ukrainian (uk)
Inventor
Патриция Феррари
Джузеппе Бьянки
Мара Ферранди
Original Assignee
Сигма-Тау Индустрие Фармасьютике Риуните С.П.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Сигма-Тау Индустрие Фармасьютике Риуните С.П.А. filed Critical Сигма-Тау Индустрие Фармасьютике Риуните С.П.А.
Publication of UA103664C2 publication Critical patent/UA103664C2/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0038—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 with an androstane skeleton, including 18- or 19-substituted derivatives, 18-nor derivatives and also derivatives where position 17-beta is substituted by a carbon atom not directly bonded to a further carbon atom and not being part of an amide group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed

Abstract

Изобретение касается применения соединения формулы (I)(I),где значения символов раскрыты в тексте; как антипротеинурического средства, антигломерулосклеротического средства или как средства для лечения почечной недостаточности.
UAA201112311A 2009-03-23 2010-03-18 5-β-ПРОИЗВОДНЫЕ 14-β-АНДРОСТАНА ДЛЯ ЛЕЧЕНИЯ ПРОТЕИНУРИИ, ГЛОМЕРУЛОСКЛЕРОЗА И ПОЧЕЧНОЙ НЕДОСТАТОЧНОСТИ UA103664C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09155834 2009-03-23
PCT/EP2010/053571 WO2010108855A1 (en) 2009-03-23 2010-03-18 5-β, 14-β-ANDROSTANE DERIVATIVES USEFUL FOR THE TREATMENT OF PROTEINURIA, GLOMERULOSCLEROSIS AND RENAL FAILURE

Publications (1)

Publication Number Publication Date
UA103664C2 true UA103664C2 (ru) 2013-11-11

Family

ID=40622086

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201112311A UA103664C2 (ru) 2009-03-23 2010-03-18 5-β-ПРОИЗВОДНЫЕ 14-β-АНДРОСТАНА ДЛЯ ЛЕЧЕНИЯ ПРОТЕИНУРИИ, ГЛОМЕРУЛОСКЛЕРОЗА И ПОЧЕЧНОЙ НЕДОСТАТОЧНОСТИ

Country Status (21)

Country Link
US (2) US20120028945A1 (ru)
EP (1) EP2411015B1 (ru)
JP (1) JP5738267B2 (ru)
KR (1) KR101656797B1 (ru)
CN (1) CN102361643B (ru)
AU (1) AU2010227644B2 (ru)
BR (1) BRPI1012240A2 (ru)
CA (1) CA2754642C (ru)
DK (1) DK2411015T3 (ru)
EA (1) EA019929B1 (ru)
ES (1) ES2559005T3 (ru)
HU (1) HUE027408T2 (ru)
IL (1) IL214477A (ru)
MX (1) MX2011009321A (ru)
NZ (1) NZ594412A (ru)
PL (1) PL2411015T3 (ru)
PT (1) PT2411015E (ru)
SG (2) SG2014010912A (ru)
UA (1) UA103664C2 (ru)
WO (1) WO2010108855A1 (ru)
ZA (1) ZA201107647B (ru)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RS54416B1 (en) * 2009-10-19 2016-04-28 Rostaquo S.P.A. ROSTAFUROXIN FOR PHARMACOGENOMIC TREATMENT OF CARDIOVASCULAR STATES
CN102940640A (zh) * 2012-12-06 2013-02-27 中国生命药物治疗有限公司 罗他夫辛在制备治疗基因缺陷型原发性高血压的药物中的用途
CN105078954A (zh) * 2015-08-20 2015-11-25 南京华宽信息咨询中心 一种治疗急性肾衰药物及其应用
CN108152432B (zh) * 2017-12-29 2020-11-20 兆科药业（合肥）有限公司 一种罗他夫辛片高效液相检测方法
US11337988B2 (en) 2018-09-27 2022-05-24 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Use of ouabain antagonists to inhibit viral infection
FI3805243T3 (fi) * 2019-10-09 2024-02-07 Windtree Therapeutics Inc Androstaanijohdannaisia, joilla on aktiivisuus puhtaina tai pääasiallisesti puhtaina SERCA2a:n stimulaattoreina, sydämen vajaatoiminnan hoitoon

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4227616C2 (de) * 1992-08-20 1995-04-13 Sigma Tau Ind Farmaceuti 17-(3-Furyl)-und 17-(4-Pyridazinyl)-5beta, 14beta-androstanderivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammemsetzungen
DE4232681C2 (de) 1992-09-29 1994-11-24 Sigma Tau Ind Farmaceuti 17-Phenyl- und 17-Furyl-14beta,5alpha-androstan- und androsten- Derivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzung
DE4232638C2 (de) 1992-09-29 1994-11-17 Sigma Tau Ind Farmaceuti 17-Phenyl-5beta-14beta-androstanderivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
TWI392682B (zh) * 2006-04-13 2013-04-11 Sigma Tau Ind Farmaceuti 作為心血管疾病的治療藥物之雄甾烷和雄甾烯的胺基衍生物
TWI389917B (zh) * 2006-04-13 2013-03-21 Sigma Tau Ind Farmaceuti 作為心血管疾病治療藥物的雄甾烷與雄甾烯之氮雜環烷基衍生物
TWI372762B (en) * 2006-06-23 2012-09-21 Sigma Tau Ind Farmaceuti Amino derivatives of b-homoandrostanes and b-heteroandrostanes
PL2160190T3 (pl) * 2007-06-07 2016-03-31 Cvie Therapeutics Ltd Pochodne 5beta, 14beta-androstanu przydatne w leczeniu chorób będących wynikiem zwłóknienia organu

Also Published As

Publication number Publication date
EA201171155A1 (ru) 2012-03-30
CN102361643A (zh) 2012-02-22
US20120028945A1 (en) 2012-02-02
EP2411015A1 (en) 2012-02-01
WO2010108855A1 (en) 2010-09-30
PT2411015E (pt) 2016-02-26
NZ594412A (en) 2013-10-25
SG2014010912A (en) 2014-06-27
JP2012521383A (ja) 2012-09-13
AU2010227644B2 (en) 2016-05-19
PL2411015T3 (pl) 2016-05-31
HUE027408T2 (en) 2016-10-28
IL214477A (en) 2017-04-30
DK2411015T3 (en) 2016-02-08
SG174260A1 (en) 2011-10-28
EP2411015B1 (en) 2015-12-23
IL214477A0 (en) 2011-09-27
US9868757B2 (en) 2018-01-16
JP5738267B2 (ja) 2015-06-24
CA2754642A1 (en) 2010-09-30
BRPI1012240A2 (pt) 2018-06-12
KR101656797B1 (ko) 2016-09-12
KR20110133027A (ko) 2011-12-09
EA019929B1 (ru) 2014-07-30
ZA201107647B (en) 2012-07-25
AU2010227644A1 (en) 2011-09-01
ES2559005T3 (es) 2016-02-10
US20160251392A1 (en) 2016-09-01
CN102361643B (zh) 2016-05-18
MX2011009321A (es) 2011-10-03
CA2754642C (en) 2016-11-08

Similar Documents

Publication Publication Date Title
UA106748C2 (ru) Производные пролина как ингибиторы катепсина
HK1173693A1 (en) Modular, portable dialysis system
AP2011005821A0 (en) Processing biomas.
EP2477693A4 (en) COUPLINGS FOR IMPLANTED CABLES AND EXTERNAL STIMULATORS AND CORRESPONDING SYSTEMS AND METHOD
AP2011005754A0 (en) Processing biomas.
AP2011005740A0 (en) Pirfenidone treatment for patients with a typical liver function.
AP2011006027A0 (en) Processing biomass.
TW201129938A (en) Personal mapping system
AP2011005815A0 (en) Processing biomass.
HK1169301A1 (zh) 用於優化組織和細胞富集的移植物的系統、方法和組合物
AP2011006029A0 (en) Processing biomass.
ZA200908903B (en) Safety luer connection
AP2010005481A0 (en) Processing biomass.
UA103664C2 (ru) 5-β-ПРОИЗВОДНЫЕ 14-β-АНДРОСТАНА ДЛЯ ЛЕЧЕНИЯ ПРОТЕИНУРИИ, ГЛОМЕРУЛОСКЛЕРОЗА И ПОЧЕЧНОЙ НЕДОСТАТОЧНОСТИ
PL2454426T3 (pl) Układ rusztowania oraz złącze, podłużnica rusztowania i stojak
AP2011005857A0 (en) Tablets for combination therapy.
HK1163078A1 (zh) -二取代呫吨鹽
AP2012006292A0 (en) Topical use of hydroxytyrosol and derivatives for the prevention of HIV infection.
WO2013170236A3 (en) Chemical modification of lignin and lignin derivatives
AP2011005868A0 (en) Modular core orientation system.
MX2012014796A (es) Proceso para preparar 4-hidroxipiridinas.
WO2010112589A3 (de) Schnittschablone aus keramik
HK1178525A1 (en) New secondary 8-hydroxyquinoline-7-carboxamide derivatives. 8--7-
MX2012003290A (es) Composicion para reducir el nivel de acido urico en la sangre.
WO2011006097A3 (en) Methods For Treating Toxicity